Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biomerieux SA Confirms FY 2013 Revenue Guidance


Tuesday, 23 Apr 2013 01:00am EDT 

Biomerieux SA announced that it has confirmed its fiscal year 2013 guidance of organic sales growth between 3% and 5%. For fiscal year 2012, the Company reported a revenue of EUR 1,570.00 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report fiscal year 2013 revenue of EUR 1,623.43 million. 

Company Quote

79.8
0.36 +0.45%
29 Aug 2014